American International Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,548
Closed -$52K 3341
2022
Q1
$52K Sell
17,548
-1,236
-7% -$4.33K ﹤0.01% 2829
2021
Q4
$90K Sell
18,784
-276
-1% -$1.78K ﹤0.01% 2764
2021
Q3
$144K Buy
19,060
+416
+2% +$2.66K ﹤0.01% 2617
2021
Q2
$139 Buy
+18,644
New +$144K ﹤0.01% 2738
2019
Q2
Sell
-7,208
Closed -$34K 3173
2019
Q1
$34K Sell
7,208
-233
-3% -$1.15K ﹤0.01% 2951
2018
Q4
$32K Buy
7,441
+2,620
+54% +$20.2K ﹤0.01% 2974
2018
Q3
$53K Buy
4,821
+86
+2% +$1.01K ﹤0.01% 3055
2018
Q2
$77K Buy
+4,735
New +$68.5K ﹤0.01% 2893

Other funds holding SURF

American International Group's SURF Position: Q2 2022 in Review

American International Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 17,548 shares — an estimated $52K sold.

American International Group first reported a position in SURF in Q2 2018 and held it in 8 quarters. The position peaked at $144K in Q3 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • American International Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 17,548 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $52K.
  • American International Group first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 8 quarters.
  • American International Group's Surface Oncology, Inc. Common Stock position peaked at $144K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.